Amatuximab Biosimilar: Advancing Mesothelin-Targeted Therapy for Cancer Amatuximab is a monoclonal antibody targeting mesothelin, a tumor-associated antigen o … read more 8th Dec 2024 Shanza Riaz
Iscalimab Biosimilar: Advancing CD40-Targeted Therapy for Immune Modulation Iscalimab (CFZ533) is a monoclonal antibody targeting CD40, a key receptor in the immu … read more 7th Dec 2024 Shanza Riaz
Ifabotuzumab Biosimilar: Advancing EGFRvIII-Targeted Cancer Therapy Ifabotuzumab is a monoclonal antibody targeting the EGFRvIII mutation, a tumor-specifi … read more 7th Dec 2024 Shanza Riaz
